Company Filing History:
Years Active: 1992
Title: Andrew Doherty: Innovator in Genetic Engineering
Introduction
Andrew Doherty is a notable inventor based in Bourne End, GB. He has made significant contributions to the field of genetic engineering, particularly through his work on the cloning and use of transaminase gene tyrB. His innovative approach has led to advancements in the production of L-phenylalanine, a crucial amino acid.
Latest Patents
Andrew holds a patent for the cloning and use of the transaminase gene tyrB. This patent details the isolation of the tyrB gene contained in E. coli ATCC 11303 and its cloning onto a multicopy plasmid. The result of this process is a remarkable 10-fold increase in the yield of L-phenylalanine after the transformation of the starting strain with this plasmid. This innovation has the potential to enhance various biotechnological applications.
Career Highlights
Andrew Doherty is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work at Hoechst has allowed him to explore and develop groundbreaking techniques in genetic engineering. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Rudiger Marquardt and Johann Then. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Andrew Doherty's contributions to genetic engineering, particularly through his patent on the tyrB gene, highlight his innovative spirit and dedication to advancing biotechnology. His work continues to influence the field and pave the way for future discoveries.